BIOFRONTERA INC.

(A3C6YA)
  Bericht
Realtime-Estimate Cboe BZX  -  16:37 09.08.2022
1.415 USD   -2.41%
01.08.Vorstand und Aufsichtsrat von Biofrontera empfehlen den Aktionären, das Übernahmeangebot der Deutschen Balaton abzulehnen
MT
01.08.Biofrontera erhält australisches Patent für photodynamische Therapie zur Behandlung von Hautkrankheiten
MT
12.07.Biofrontera Inc. gibt eine Umsatzprognose für das zweite Quartal und die sechs Monate bis zum 30. Juni 2022 ab
CI
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über BIOFRONTERA INC.
04.08.Biofrontera Inc. to Report Second Quarter Financial Results on August 12, 2022
04.08.Biofrontera Inc. to Report Second Quarter Financial Results on August 12, 2022
01.08.Biofrontera's Management, Supervisory Boards Recommend Shareholders Reject Deutsche Bal..
01.08.Biofrontera Receives Australian Patent for Photodynamic Therapy to Treat Skin Diseases
01.08.Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted..
28.07.BIOFRONTERA : Announces Exercise of Existing Warrants and Issuance of Warrants in Private ..
28.07.BIOFRONTERA INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity..
27.07.Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Pr..
27.07.Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Pr..
12.07.BIOFRONTERA : Announces Preliminary Product Revenues for the Second Quarter of 2022 - Form..
12.07.Biofrontera Inc. Announces Preliminary Product Revenues for the Second Quarter of 2022
12.07.Biofrontera Inc. Announces Preliminary Product Revenues for the Second Quarter of 2022
12.07.Biofrontera Inc. Provides Revenue Guidance for the Second Quarter and Six Months Ended ..
24.06.BIOFRONTERA INC.(NASDAQCM : BFRI) dropped from Russell 3000E Value Index
24.06.BIOFRONTERA INC.(NASDAQCM : BFRI) dropped from Russell Microcap Value Index
09.06.Biofrontera, Inc. Recognized for Rapid Sales Growth, Innovative Therapies and Marketing..
09.06.Biofrontera, Inc. Recognized for Rapid Sales Growth, Innovative Therapies and Marketing..
31.05.Biofrontera Inc. to Participate in The Benchmark Healthcare House Call Virtual 1x1 Conf..
31.05.Biofrontera Inc. to Participate in The Benchmark Healthcare House Call Virtual 1x1 Conf..
24.05.BIOFRONTERA INC. : Change in Directors or Principal Officers, Other Events, Financial Stat..
24.05.BIOFRONTERA INC. Change in Directors or Principal Officers (form 8-K/A)
24.05.Biofrontera Inc. Appoints Kevin D. Weber to the Nominating and Corporate Governance, Au..
24.05.New Data and Forecasts for the U.S. Skin Cancer Market Strongly Support the Commercial ..
23.05.Biofrontera Inc. announced that it has received $9.40068 million in funding
20.05.BIOFRONTERA : Announces Pricing of $9.4 Million Private Placement - Form 8-K
20.05.BIOFRONTERA INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity..
19.05.Biofrontera Inc. Announces Closing of $9.4 Million Private Placement
16.05.Biofrontera Inc. Announces Pricing of $9.4 Million Private Placement
16.05.Biofrontera Inc. Announces Pricing of $9.4 Million Private Placement
16.05.Biofrontera Inc. announced that it expects to receive $9.40225 million in funding
13.05.Earnings Flash (BFRI) BIOFRONTERA Posts Q1 Revenue $9.8M, vs. Street Est of $9.83M
13.05.Biofrontera Inc. Reports First Quarter 2022 Financial Results and Provides a Business U..
13.05.Biofrontera Inc. Reports First Quarter 2022 Financial Results and Provides a Business U..
13.05.Biofrontera Inc. Re-Affirms Earnings Guidance for 2022
13.05.BIOFRONTERA INC. Management's Discussion and Analysis of Financial Condition and Resul..
13.05.Biofrontera Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
06.05.Biofrontera Inc. to Report First Quarter Financial Results on May 13, 2022
06.05.Biofrontera Inc. to Report First Quarter Financial Results on May 13, 2022
05.05.Biofrontera Inc. to Showcase Actinic Keratosis Treatments at the Music City Symposium f..
05.05.Biofrontera Inc. to Showcase Actinic Keratosis Treatments at the Music City Symposium f..
27.04.Certain Common Stock of Biofrontera Inc. are subject to a Lock-Up Agreement Ending on 2..
21.04.Biofrontera Launches New Patient-Focused Websites for Ameluz® and Xepi®
14.04.Biofrontera Shares Retreat 7% After Wednesday's Big Move Higher
13.04.Top Midday Gainers
13.04.Biofrontera Shares Jump 31% After FDA Approves Contract Laboratory for Ameluz
13.04.Biofrontera Says FDA Has Approved German Facility as Contract Laboratory for Testing of..
13.04.Biofrontera Shares Halted After FDA Approves German Lab for Testing Ameluz
13.04.Biofrontera Inc. Announces FDA Approval of Biofrontera Pharma GmbH as a Contract Labora..
11.04.Top Premarket Decliners
11.04.BIOFRONTERA INC. Management's Discussion and Analysis of Financial Condition and Resul..
08.04.SECTOR UPDATE : Health Care Stocks Enjoy Late Uptick
08.04.SECTOR UPDATE : Health Care Stocks Firming in Mostly Higher Market
08.04.SECTOR UPDATE : Health Care
08.04.European ADRs Move Higher in Friday Trading
08.04.Biofrontera Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended De..
08.04.Top Premarket Gainers
08.04.Earnings Flash (BFRI) BIOFRONTERA Reports Q4 Revenue $9.2M, vs. Street Est of $9.2M
08.04.Biofrontera Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provid..
06.04.BIOFRONTERA : Announces Preliminary Product Revenues for the First Quarter of 2022 - Form ..
06.04.Biofrontera Inc. Announces Preliminary Product Revenues for the First Quarter of 2022
06.04.Biofrontera Inc. Announces Preliminary Product Revenues for the First Quarter of 2022
05.04.BIOFRONTERA INC. : Entry into a Material Definitive Agreement, Change in Directors or Prin..
04.04.European ADRs Nudge Higher in Monday Trading
01.04.Biofrontera Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on April..
30.03.European ADRs Move Higher in Wednesday Trading
17.03.Biofrontera to Showcase Actinic Keratoses and Impetigo Treatments at the 2022 American ..
17.03.European ADRs Nudge Higher in Thursday Trading
14.03.Biofrontera Inc. Announces FDA Orange Book Listing of U.S. Patent for BF-RhodoLED® XL, ..
09.03.Biofrontera Inc. to Present at the 34th Annual Roth Conference
08.03.BIOFRONTERA INC. : Change in Directors or Principal Officers, Financial Statements and Exh..
07.03.Biofrontera Inc. Appoints Kevin D. Weber to its Board of Directors
07.03.Biofrontera Inc. Appoints Kevin D. Weber to its Board of Directors
01.02.Top Midday Gainers
01.02.Biofrontera Completes 70% of Enrollment in Phase 3 of Skin Cancer Study; Shares Rise
01.02.Biofrontera Inc. provides Update on Patient Recruitment for Phase III Study for the Tre..
1  2Weiter
Anstehende Termine für BIOFRONTERA INC.